Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Veracyte Inc
VCYTCurrent price
31.82 USD
-0.02 USD (-0.06%)
Last closed
31.78 USD
Company
www.veracyte.com
ISIN
US92337F1075
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Capitalization
3 358 057 728 USD
Yield for 12 month
+51.52 %
1Y
3Y
5Y
10Y
15Y
VCYT
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
42.67 USDP/E ratio
–Dividend Yield
–Current Year
+361 051 000 USD
Last Year
+296 536 000 USD
Current Quarter
+115 860 000 USD
Last Quarter
+114 428 000 USD
Current Year
+248 148 000 USD
Last Year
+194 954 000 USD
Current Quarter
+79 010 000 USD
Last Quarter
+75 785 000 USD
Key Figures VCYT
1 year
3 years
5 years
10 years
EBITDA
44 014 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
1.07 %
PEG Ratio
–
Return On Equity TTM
-0.83 %
Wall Street Target Price
42.67 USD
Revenue TTM
425 331 008 USD
Book Value
15.18 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
28.60 %
Dividend Yield
–
Gross Profit TTM
194 954 000 USD
Earnings per share
-0.13 USD
Diluted Eps TTM
-0.13 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-2.18 %
Dividend Analytics VCYT
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History VCYT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation VCYT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
45.87
Enterprise Value Revenue
7.28
Price Sales TTM
7.90
Enterprise Value EBITDA
179.53
Price Book MRQ
2.85
Financials VCYT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VCYT
For 52 weeks
18.61 USD
46.00 USD
50 Day MA
37.51 USD
Shares Short Prior Month
2 876 243
200 Day MA
27.71 USD
Short Ratio
3.41
Shares Short
2 966 704
Short Percent
4.27 %
BeatStart